Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells: Combination of HDAC and Aurora inhibitors in BCR-ABL-expressing cellsSeiichi Okabe, Kazuma Ohyashiki|Cancer Cell International|2013Cited by 21
Therapeutic targeting of Aurora A kinase in Philadelphia chromosome-positive ABL tyrosine kinase inhibitor-resistant cellsSeiichi Okabe, Kazuma Ohyashiki|Oncotarget|2018Cited by 9
Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditionsSeiichi Okabe, Akihiko Gotoh|Research Square|2021Cited by 0